"Nail loss after teriflunomide treatment: A new potential adverse event".

Multiple sclerosis and related disorders(2017)

引用 5|浏览9
暂无评分
摘要
Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility and evaluate treatment discontinuation.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要